1978
DOI: 10.1248/cpb.26.1123
|View full text |Cite
|
Sign up to set email alerts
|

Absolute configurations of four isomers of 3-formamido-4-hydroxy-.ALPHA.-[[N-(p-methoxy-.ALPHA.-methylphenethyl)amino]methyl]benzyl alcohol, a potent .BETA.-adrenoreceptor stimulant.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 34 publications
(20 citation statements)
references
References 0 publications
0
20
0
Order By: Relevance
“…For example, (S)-amphetamine has higher pharmacologically activity as stimulant [4] and hyperthermic agent [5] than its (R)-enantiomer; (R)-4-phenylbutan-2-amine (2a) is a precursor of the anti-hypertensive dilevalol, [6] and (R)-p-methoxyamphetamine (2d) is a constituent of (R,R)-formoterol, a potent bronchodilator. [7] Furthermore 1-phenyl-1-propylamine (2c) is a precursor of the corticotropin-releasing factor type-1 receptor antagonist, a potent anti-depressive agent. [8] Consequently, there is a need for efficient methods to obtain the desired (R)-or (S)-enantiomer in optically pure form starting from easily accessible ketone.…”
Section: Introductionmentioning
confidence: 99%
“…For example, (S)-amphetamine has higher pharmacologically activity as stimulant [4] and hyperthermic agent [5] than its (R)-enantiomer; (R)-4-phenylbutan-2-amine (2a) is a precursor of the anti-hypertensive dilevalol, [6] and (R)-p-methoxyamphetamine (2d) is a constituent of (R,R)-formoterol, a potent bronchodilator. [7] Furthermore 1-phenyl-1-propylamine (2c) is a precursor of the corticotropin-releasing factor type-1 receptor antagonist, a potent anti-depressive agent. [8] Consequently, there is a need for efficient methods to obtain the desired (R)-or (S)-enantiomer in optically pure form starting from easily accessible ketone.…”
Section: Introductionmentioning
confidence: 99%
“…Because of the two stereocenters in the molecule structure, there are four different stereoisomers that demonstrate different pharmacological potencies, respectively, the order is (R,R)>(R,S))(S,R)>(S,S). 1 Toxicology studies indicated that the (S,S)-isomer is toxic in a manner independent of b 2 -adrenoceptor binding and may increase the toxicological burden of the racemic drug. 2 Therefore, the use of (R,R)-Formoterol for asthma could eliminate adverse effects of (S,S)-Formoterol that arise during therapeutic use.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the unique strongpoint of (R,R)-Formoterol, there were few reports of the asymmetric synthesis of this useful chiral drug. Murase et al 1 described a preparation employing a resolution process of two enantiomers. Trofast et al 3 reported a HPLC-semipreparative separation of diastereomers.…”
Section: Introductionmentioning
confidence: 99%
“…The order of potency is (R,R ) » (R,S ) = (S,R) > (S,S) [57]. The order of potency is (R,R ) » (R,S ) = (S,R) > (S,S) [57].…”
Section: Formoterol-perforomistmentioning
confidence: 99%